The global coronavirus disease 2019 (COVID-19) pandemic rages on. To date, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of COVID-19, has infected over 138.3 million and caused over 2.9 million deaths the world over. Despite major gains…
Read More
CN Bio introduces the PhysioMimix™ OOC Multi-Organ Microphysiological System
CN Bio, a leading developer of single and multi-organ microphysiological systems (MPS), otherwise known as organ-on-a-chip (OOC), today announced the commercial launch of its new PhysioMimix™ OOC Multi-Organ MPS. The next-generation platform combines CN Bio’s in vitro 3D liver model,…
Read More
In Vitro vs In Vivo Preclinical Studies
Before a drug candidate can be tested in humans, its safety and efficacy must be explored in preclinical studies. These studies can either be ‘in vitro’, Latin for “within the glass” and referring to studies using cell cultures studied outside…
Read More
Novel hybrid device to boost research on metastatic process of breast cancer cells
European researchers are working on a novel hybrid device to better understand the metastatic process of cancer cells traveling from breast to bone and fast screen new drugs against it. The spread of cancer cells to other parts of the…
Read More
Zinc supplementation bolsters repurposed antivirals against SARS-CoV-2
Since the beginning of the coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pathogen, serious efforts have been made to identify new or repurposable drugs that effectively inhibit or counteract the infection. A…
Read More
Orgalutran
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. ORGALUTRAN® Ganirelix (as acetate) 250 micrograms in 0.5 millilitres Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about Orgalutran. It does…
Read More